This list contains only the countries for which job offers have been published in the selected language (e.g., in the French version, only job offers written in French are displayed, and in the English version, only those in English).
GSK is seeking a highly skilled and visionary Director, Portfolio Decision Sciences to partner with the Head, Portfolio Decision Sciences, Oncology in supporting GSK’s Oncology and broader Pharmaceutical portfolio across the entire R&D lifecycle – from preclinical research through late‑stage clinical development. In this influential role, you will work directly with project teams and governance boards to evaluate investment opportunities in areas of high uncertainty and limited data. You will play a pivotal part in guiding technical progression and investment decisions through systematic risk assessment, probabilistic evaluation, and rigorous economic analysis (e.g., ROI, NPV). Your insights will inform key decision‑making bodies including the Portfolio Investment Board (PIB), Development Review Board (DRB) and Research Unit Investment Boards. You will shape strategically differentiated options, drive challenging conversations with senior leaders, and leverage cutting‑edge data and technology trends to enable high‑quality portfolio decision making. The ideal candidate is an intellectually curious portfolio expert with deep R&D experience, a passion for innovation, and the ability to navigate and influence broadly across the Oncology and R&D ecosystems at GSK.
Job Responsibility:
Guiding project teams across the R&D lifecycle (including BD opportunities) using strategic decision frameworks, probability‑of‑success elicitation, and economic evaluations (ROI, NPV), facilitating decision making and generating project‑ and portfolio‑level insights
Delivering objective project assessments for R&D investment decisions at Research Unit governance bodies, and the Portfolio Investment Board (PIB)
Providing clear, rigorous recommendations to governance chairs based on detailed value‑risk analyses, option evaluations, resource considerations, and risk‑discharge points
Leading portfolio‑ or indication‑level assessments to inform senior leaders on prioritisation decisions across scientific, commercial, operational, strategic and financial dimensions
Supporting the biannual dynamic Portfolio Review (dPR) for Oncology, ensuring refreshed project assessments and surfacing emerging investment opportunities
Collaborating across finance, portfolio management, strategy, operations, and Research Units to recommend short‑ and long‑term focus areas and enable optimal resource deployment
Driving portfolio management excellence by monitoring the external environment, evaluating innovative portfolio approaches, and proposing use cases applicable to GSK
Enhancing the development and deployment of advanced analytics, including AI and machine learning, to elevate decision‑making quality across teams and senior leadership
Requirements:
Bachelor’s degree in Science or Business
PhD, MD, or advanced scientific/decision sciences degree preferred
Demonstrated experience in pharmaceutical, healthcare, or related industries
Strong understanding of R&D processes, ideally with experience supporting or leading drug‑development teams
Proven track record of independently delivering complex projects
Experience navigating cross‑functional teams and enabling change
High learning agility
ability to facilitate complex scientific, technical, value, and resourcing discussions
Ability to translate detailed scientific and technical insights into concise, impactful recommendations
Strong relationship‑building skills to become a trusted strategic partner to project teams and senior leaders
Ability to manage multiple projects, priorities, and fast‑paced decision cycles